Cargando…
Production of Four (15)N-Labelled Cobalamins via Biosynthesis Using Propionibacterium freudenreichii
Cobalamins (vitamin B12) are required by humans for their essential roles as enzyme cofactors in diverse metabolic processes. The four most common cobalamin vitamers are hydroxocobalamin (OHCbl), adenosylcobalamin (AdoCbl), methylcobalamin (MeCbl), and cyanocobalamin (CNCbl). Humans are not able to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414983/ https://www.ncbi.nlm.nih.gov/pubmed/34484151 http://dx.doi.org/10.3389/fmicb.2021.713321 |
_version_ | 1783747885834174464 |
---|---|
author | Wang, Mengle Asam, Stefan Chen, Jianqi Ehrmann, Matthias Rychlik, Michael |
author_facet | Wang, Mengle Asam, Stefan Chen, Jianqi Ehrmann, Matthias Rychlik, Michael |
author_sort | Wang, Mengle |
collection | PubMed |
description | Cobalamins (vitamin B12) are required by humans for their essential roles as enzyme cofactors in diverse metabolic processes. The four most common cobalamin vitamers are hydroxocobalamin (OHCbl), adenosylcobalamin (AdoCbl), methylcobalamin (MeCbl), and cyanocobalamin (CNCbl). Humans are not able to synthesise cobalamins de novo and thus must acquire them from external sources. Therefore, a reliable and robust analytical method to determine the cobalamins in dietary sources is highly required. For such a purpose, stable isotope dilution assays (SIDAs) with LC-MS/MS are most suited due to their superior sensitivity, specificity, and ability to compensate for matrix effects and analyte loss during sample work-up. However, a critical bottleneck for developing a SIDA method for cobalamins is the availability of stable isotope-labelled internal standards. In the present study, we harnessed the potential of Propionibacterium (P.) freudenreichii for the biosynthesis of (15)N-labelled cobalamins. First, we developed a chemically defined medium (CDM) containing ammonium sulphate as a single nitrogen source except three essential vitamins that supported long-term stable growth of P. freudenreichii throughout continuous transfers. The CDM was further optimised for cobalamin production under different incubation schemes. With the optimised CDM and incubation scheme, fully (15)N-labelled cobalamins were obtained in P. freudenreichii with a final yield of 312 ± 29 μg/L and 635 ± 102 μg/L, respectively, for [(15)N]-OHCbl and [(15)N]-AdoCbl. Additionally, an optimised incubation process under anaerobic conditions was successfully employed to produce specifically labelled [(15)N, (14)N(2)]-cobalamins, with a yield of 96 ± 18 μg/L and 990 ± 210 μg/L, respectively, for [(15)N, (14)N(2)]-OHCbl and [(15)N, (14)N(2)]-AdoCbl. The labelled substances were isolated and purified by solid phase extraction and semi-preparative HPLC. Chemical modifications were carried out to produce [(15)N]-CNCbl and [(15)N]-MeCbl. Eventually, (15)N-labelled compounds were obtained for the four cobalamin vitamers in high chromatographic and isotopic purity with desired (15)N-enrichment and labelling patterns, which are perfectly suited for future use in SIDAs or other applications that require isotopologues. |
format | Online Article Text |
id | pubmed-8414983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84149832021-09-04 Production of Four (15)N-Labelled Cobalamins via Biosynthesis Using Propionibacterium freudenreichii Wang, Mengle Asam, Stefan Chen, Jianqi Ehrmann, Matthias Rychlik, Michael Front Microbiol Microbiology Cobalamins (vitamin B12) are required by humans for their essential roles as enzyme cofactors in diverse metabolic processes. The four most common cobalamin vitamers are hydroxocobalamin (OHCbl), adenosylcobalamin (AdoCbl), methylcobalamin (MeCbl), and cyanocobalamin (CNCbl). Humans are not able to synthesise cobalamins de novo and thus must acquire them from external sources. Therefore, a reliable and robust analytical method to determine the cobalamins in dietary sources is highly required. For such a purpose, stable isotope dilution assays (SIDAs) with LC-MS/MS are most suited due to their superior sensitivity, specificity, and ability to compensate for matrix effects and analyte loss during sample work-up. However, a critical bottleneck for developing a SIDA method for cobalamins is the availability of stable isotope-labelled internal standards. In the present study, we harnessed the potential of Propionibacterium (P.) freudenreichii for the biosynthesis of (15)N-labelled cobalamins. First, we developed a chemically defined medium (CDM) containing ammonium sulphate as a single nitrogen source except three essential vitamins that supported long-term stable growth of P. freudenreichii throughout continuous transfers. The CDM was further optimised for cobalamin production under different incubation schemes. With the optimised CDM and incubation scheme, fully (15)N-labelled cobalamins were obtained in P. freudenreichii with a final yield of 312 ± 29 μg/L and 635 ± 102 μg/L, respectively, for [(15)N]-OHCbl and [(15)N]-AdoCbl. Additionally, an optimised incubation process under anaerobic conditions was successfully employed to produce specifically labelled [(15)N, (14)N(2)]-cobalamins, with a yield of 96 ± 18 μg/L and 990 ± 210 μg/L, respectively, for [(15)N, (14)N(2)]-OHCbl and [(15)N, (14)N(2)]-AdoCbl. The labelled substances were isolated and purified by solid phase extraction and semi-preparative HPLC. Chemical modifications were carried out to produce [(15)N]-CNCbl and [(15)N]-MeCbl. Eventually, (15)N-labelled compounds were obtained for the four cobalamin vitamers in high chromatographic and isotopic purity with desired (15)N-enrichment and labelling patterns, which are perfectly suited for future use in SIDAs or other applications that require isotopologues. Frontiers Media S.A. 2021-08-13 /pmc/articles/PMC8414983/ /pubmed/34484151 http://dx.doi.org/10.3389/fmicb.2021.713321 Text en Copyright © 2021 Wang, Asam, Chen, Ehrmann and Rychlik. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Wang, Mengle Asam, Stefan Chen, Jianqi Ehrmann, Matthias Rychlik, Michael Production of Four (15)N-Labelled Cobalamins via Biosynthesis Using Propionibacterium freudenreichii |
title | Production of Four (15)N-Labelled Cobalamins via Biosynthesis Using Propionibacterium freudenreichii |
title_full | Production of Four (15)N-Labelled Cobalamins via Biosynthesis Using Propionibacterium freudenreichii |
title_fullStr | Production of Four (15)N-Labelled Cobalamins via Biosynthesis Using Propionibacterium freudenreichii |
title_full_unstemmed | Production of Four (15)N-Labelled Cobalamins via Biosynthesis Using Propionibacterium freudenreichii |
title_short | Production of Four (15)N-Labelled Cobalamins via Biosynthesis Using Propionibacterium freudenreichii |
title_sort | production of four (15)n-labelled cobalamins via biosynthesis using propionibacterium freudenreichii |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414983/ https://www.ncbi.nlm.nih.gov/pubmed/34484151 http://dx.doi.org/10.3389/fmicb.2021.713321 |
work_keys_str_mv | AT wangmengle productionoffour15nlabelledcobalaminsviabiosynthesisusingpropionibacteriumfreudenreichii AT asamstefan productionoffour15nlabelledcobalaminsviabiosynthesisusingpropionibacteriumfreudenreichii AT chenjianqi productionoffour15nlabelledcobalaminsviabiosynthesisusingpropionibacteriumfreudenreichii AT ehrmannmatthias productionoffour15nlabelledcobalaminsviabiosynthesisusingpropionibacteriumfreudenreichii AT rychlikmichael productionoffour15nlabelledcobalaminsviabiosynthesisusingpropionibacteriumfreudenreichii |